Antibiotic-resistant bacteria are not only a threat to public health in the United States, but also to national health security. The federal government has recognized that antibiotic-resistant pathogens complicate wound care, exacerbate casualties associated with both natural and manmade emergencies, and can be weaponized by our nation’s enemies. In this Q&A published by Pew, ASPR’s BARDA Director Rick Bright explains what is being done to reduce the emergence and spread of such superbugs both domestically and internationally, and accelerate the development of new drugs, diagnostic tests, and vaccines.

Nominations Now Being
Accepted for NACCHO/ASPR
National Health Security Awards

Know the Signs of Sepsis?
DRIVe and Sepsis Alliance Launch Sepsis Education/Training Initiative

DRIVe Teams up with
Emory University to Develop
Machine Learning Software for
Early Warning of Sepsis in Patients

DRIVe Partners with Immunexpress
on Ground-breaking Technology
Using Mathematical Algorithms to
Rapidly Identify Sepsis

Complex, Challenging, and
Rewarding: Developing Strategies
to Support Health and Human
Services Recovery in Puerto Rico

Whole-of-Government Approach:
What It Means and How It
Translates to Improving
National Health Security

Hospital-based Incident Command
Systems: Small and Rural Hospitals
ASPR TRACIE Webinar
Scheduled for March 12

Webinar Recording Now Available:
ASPR Healthcare and Public Health
Risk Identification and Site
Criticality (RISC) Toolkit